Following the recently described 4-1BBL antibody fusion protein design [24], different CEA-4-1BBL antibody fusion proteins were generated using five different human CEACAM5-specific antibodies for tumor targeting (Figure 1A). The gene discussed is CEACAM5; the disease is neoplasm.